Literature DB >> 16581736

High rates of syphilis among STI patients are contributing to the spread of HIV-1 in India.

S J Reynolds1, A R Risbud, M E Shepherd, A M Rompalo, M V Ghate, S V Godbole, S N Joshi, A D Divekar, R R Gangakhedkar, R C Bollinger, S M Mehendale.   

Abstract

BACKGROUND: Recent syphilis outbreaks have raised concern regarding the potential enhancement of HIV transmission. The incidence of syphilis and its association with HIV-1 infection rates among a cohort of sexually transmitted infection (STI) clinic attendees was investigated.
METHODS: 2732 HIV-1 seronegative patients attending three STI and one gynaecology clinic, were enrolled from 1993-2000 in an ongoing prospective cohort study of acute HIV-1 infection in Pune, India. At screening and quarterly follow up visits, participants underwent HIV-1 risk reduction counselling, risk behaviour assessment and HIV/STI screening that included testing for serological evidence of syphilis by RPR with TPHA confirmation. Patients with genital ulcers were screened with dark field microscopy.
RESULTS: Among 2324 participants who were HIV-1 and RPR seronegative at baseline, 172 participants were found to have clinical or laboratory evidence of syphilis during follow up (5.4 per 100 person years, 95% CI 4.8 to 6.5 per 100 person years). Independent predictors of syphilis acquisition based on a Cox proportional hazards model included age less than 20 years, lack of formal education, earlier calendar year of follow up, and recent HIV-1 infection. Based on a median follow up time of 11 months, the incidence of HIV-1 was 5.8 per 100 person years (95% CI 5.0 to 6.6 per 100 person years). Using a Cox proportional hazards model to adjust for known HIV risk factors, the adjusted hazard ratio of HIV-1 infection associated with incident syphilis was 4.44 (95% CI 2.96 to 6.65; p<0.001).
CONCLUSIONS: A high incidence rate of syphilis was observed among STI clinic attendees. The elevated risk of HIV-1 infection that was observed among participants with incident syphilis supports the hypothesis that syphilis enhances the sexual transmission of HIV-1 and highlights the importance of early diagnosis and treatment of syphilis.

Entities:  

Mesh:

Year:  2006        PMID: 16581736      PMCID: PMC2564682          DOI: 10.1136/sti.2005.015040

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  41 in total

1.  Sexually transmitted infections in long distance truck drivers.

Authors:  A V Gawande; N D Vasudeo; S P Zodpey; D W Khandait
Journal:  J Commun Dis       Date:  2000-09

2.  Interpretation and use of the western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections.

Authors: 
Journal:  MMWR Suppl       Date:  1989-07-21

3.  Risk factors for human immunodeficiency virus (HIV) infections in homosexual men.

Authors:  W W Darrow; D F Echenberg; H W Jaffe; P M O'Malley; R H Byers; J P Getchell; J W Curran
Journal:  Am J Public Health       Date:  1987-04       Impact factor: 9.308

4.  Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention.

Authors:  F X Mbopi-Kéou; G Grésenguet; P Mayaud; H A Weiss; R Gopal; M Matta; J L Paul; D W Brown; R J Hayes; D C Mabey; L Bélec
Journal:  J Infect Dis       Date:  2000-09-08       Impact factor: 5.226

5.  Risk factors and changes in sexual behavior in male homosexuals who seroconverted for human immunodeficiency virus antibodies.

Authors:  C L Kuiken; G J van Griensven; E M de Vroome; R A Coutinho
Journal:  Am J Epidemiol       Date:  1990-09       Impact factor: 4.897

6.  The association of herpes simplex virus type 2 (HSV-2), Haemophilus ducreyi, and syphilis with HIV infection in young men in northern Thailand.

Authors:  K E Nelson; S Eiumtrakul; D Celentano; I Maclean; A Ronald; S Suprasert; D R Hoover; S Kuntolbutra; J M Zenilman
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-12-01

7.  The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania.

Authors:  S H Kapiga; E F Lyamuya; G K Lwihula; D J Hunter
Journal:  AIDS       Date:  1998-01-01       Impact factor: 4.177

8.  HIV-1 seroconversion in patients with and without genital ulcer disease. A prospective study.

Authors:  E E Telzak; M A Chiasson; P J Bevier; R L Stoneburner; K G Castro; H W Jaffe
Journal:  Ann Intern Med       Date:  1993-12-15       Impact factor: 25.391

9.  Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes.

Authors:  J K Kreiss; R Coombs; F Plummer; K K Holmes; B Nikora; W Cameron; E Ngugi; J O Ndinya Achola; L Corey
Journal:  J Infect Dis       Date:  1989-09       Impact factor: 5.226

10.  HIV-1 DNA shedding in genital ulcers and its associated risk factors in Pune, India.

Authors:  D A Gadkari; T C Quinn; R R Gangakhedkar; S M Mehendale; A D Divekar; A R Risbud; K Chan-Tack; M Shepherd; C Gaydos; R C Bollinger
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-07-01
View more
  30 in total

1.  Drug-related behaviors independently associated with syphilis infection among female sex workers in two Mexico-US border cities.

Authors:  Oralia Loza; Thomas L Patterson; Melanie Rusch; Gustavo A Martínez; Remedios Lozada; Hugo Staines-Orozco; Carlos Magis-Rodríguez; Steffanie A Strathdee
Journal:  Addiction       Date:  2010-04-27       Impact factor: 6.526

2.  Molecular subtyping of Treponema pallidum during a local syphilis epidemic in men who have sex with men in Melbourne, Australia.

Authors:  Francesca Azzato; Norbert Ryan; Janet Fyfe; David E Leslie
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

3.  Estimating prevalence and incidence of sexually transmitted infections among South African women: Implications of combined impacts of risk factors.

Authors:  Handan Wand; Tarylee Reddy; Reshmi Dassaye; Jothi Moodley; Sarita Naidoo; Gita Ramjee
Journal:  Int J STD AIDS       Date:  2020-09-03       Impact factor: 1.359

4.  HIV and syphilis among men who have sex with men in China: the time to act is now.

Authors:  Kathryn E Muessig; Joseph D Tucker; Bao-Xi Wang; Xiang-Sheng Chen
Journal:  Sex Transm Dis       Date:  2010-04       Impact factor: 2.830

Review 5.  The immunopathobiology of syphilis: the manifestations and course of syphilis are determined by the level of delayed-type hypersensitivity.

Authors:  J Andrew Carlson; Ganary Dabiri; Bernard Cribier; Stewart Sell
Journal:  Am J Dermatopathol       Date:  2011-07       Impact factor: 1.533

6.  Integrated syphilis/HIV screening in China: a qualitative analysis.

Authors:  Joseph D Tucker; Li-Gang Yang; Zheng-Jun Zhu; Bin Yang; Yue-Pin Yin; Myron S Cohen; Xiang-Sheng Chen
Journal:  BMC Health Serv Res       Date:  2010-03-07       Impact factor: 2.655

7.  Population-based seroprevalence of HSV-2 and syphilis in Andhra Pradesh state of India.

Authors:  John A Schneider; Vemu Lakshmi; Rakhi Dandona; G Anil Kumar; Talasila Sudha; Lalit Dandona
Journal:  BMC Infect Dis       Date:  2010-03-09       Impact factor: 3.090

8.  Syphilis treatment response among HIV-discordant couples in Zambia and Rwanda.

Authors:  Jodie Dionne-Odom; Etienne Karita; William Kilembe; Faith Henderson; Bellington Vwalika; Roger Bayingana; Zhigang Li; Joseph Mulenga; Elwyn Chomba; Carlos Del Rio; Naw Htee Khu; Amanda Tichacek; Susan Allen
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

Review 9.  The oral mucosa immune environment and oral transmission of HIV/SIV.

Authors:  Lianna F Wood; Ann Chahroudi; Hui-Ling Chen; Heather B Jaspan; Donald L Sodora
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

10.  Risk of syphilis in STI clinic patients: a cross-sectional study of 11,500 cases in Guangxi, China.

Authors:  Susan P Y Wong; Yue-Ping Yin; Xing Gao; Wan-Hui Wei; Mei-Qin Shi; Pei-Yong Huang; Hong Wang; Qiang Chen; Musang Liu; Joseph D Tucker; Xiang-Sheng Chen; Myron S Cohen
Journal:  Sex Transm Infect       Date:  2007-06-25       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.